IMI-JU-11-2013-05
IMI-JU-11-2013-05
1 project · €21,200,000 total EU contribution (project-level) · 10 participating organizations · 6 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€21,200,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (4)
- CH (2)
- BE (1)
- CA (1)
- Germany (1)
- SE (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- BAYER AKTIENGESELLSCHAFT1 projects · DE
- DRX1 projects · UK
- ETH Zürich1 projects · CH
- JANSSEN PHARMACEUTICA NV1 projects · BE
- KI1 projects · SE
- NOVARTIS1 projects · CH
- PFIZER1 projects · UK
- SGC1 projects · UK
- UOXF1 projects · UK
- UNIVERSITY OF TORONTO1 projects · CA
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Unrestricted Leveraging of Targets for Research Advancement and Drug Discovery ULTRA-DD · 115766 | FP7 | €21,200,000 | €50,308,785 | Details |